Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Dropped 23.3% in 2022

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 93.6 million yuan in 2022, down 23.3% year-on-year.
Meanwhile, the company posted 1.1 billion yuan in revenue, up 5% year-on-year.
At the end of the reporting period, it had 5.3 billion yuan in total assets and 941.7 million yuan in total liabilities, with a liability-to-asset ratio of 17.8%.
- PODCAST
- MOST POPULAR